The CareStart™ COVID-19 MDx RT-PCR molecular test provides a critical new resource in the fight against COVID-19 with a processing time of approximately 83 minutes.

The CareStart™ COVID-19 MDx RT-PCR test is an FDA EUA authorized molecular test for distribution and use by healthcare professionals and health systems conducting COVID-19 testing with 100% PPA/NPA results.

Analysis can be run on some of the most common PCR processing machines, such as Bio-Rad’s CFX96 Dx system, Thermo Fisher Scientific’s Applied Biosystems 7500, or 7500 Fast RT-PCR instrument.

• Detect two gene regions and simultaneously detect N gene as well as RdRP gene of SARS-2 CoV.
• Preventing contamination using the UDG (UracilDNA Glycosylase System).
• Internal control included for sample extraction and amplification efficiency verification
• Reaction time within 83 minutes improving laboratory efficiency.